Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline What tail risk New NMFCZ Neutral 20260427 HIG The reports 10 Q1 2026 EPS miss stock falls 37 on weak investor reaction